Literature DB >> 11069989

Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor.

A Dotzauer1, U Gebhardt, K Bieback, U Göttke, A Kracke, J Mages, S M Lemon, A Vallbracht.   

Abstract

The mechanisms underlying the hepatotropism of hepatitis A virus (HAV) and the relapsing courses of HAV infections are unknown. In this report, we show for a mouse hepatocyte model that HAV-specific immunoglobulin A (IgA) mediates infection of hepatocytes with HAV via the asialoglycoprotein receptor, which binds and internalizes IgA molecules. Proof of HAV infection was obtained by detection of HAV minus-strand RNA, which is indicative for virus replication, and quantification of infectious virions. We demonstrate that human hepatocytes also ingest HAV-anti-HAV IgA complexes by the same mechanism, resulting in infection of the cells, by using the HepG2 cell line and primary hepatocytes. The relevance of this surrogate receptor mechanism in HAV pathogenesis lies in the fact that HAV, IgA, and antigen-IgA complexes use the same pathway within the organism, leading from the gastrointestinal tract to the liver via blood and back to the gastrointestinal tract via bile fluid. Therefore, HAV-specific IgA antibodies produced by gastrointestinal mucosa-associated lymphoid tissue may serve as carrier and targeting molecules, enabling and supporting HAV infection of IgA receptor-positive hepatocytes and, in the case of relapsing courses, allowing reinfection of the liver in the presence of otherwise neutralizing antibodies, resulting in exacerbation of liver disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069989      PMCID: PMC113174          DOI: 10.1128/jvi.74.23.10950-10957.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  A novel IgA receptor expressed on a murine B cell lymphoma.

Authors:  T D Rao; A A Maghazachi; A V González; J M Phillips-Quagliata
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

2.  Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines.

Authors:  A J Zajac; E M Amphlett; D J Rowlands; D V Sangar
Journal:  J Gen Virol       Date:  1991-07       Impact factor: 3.891

3.  Susceptibility of nonprimate cell lines to hepatitis A virus infection.

Authors:  A Dotzauer; S M Feinstone; G Kaplan
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Elimination of intestinally absorbed antigen into the bile by IgA.

Authors:  T A Brown; M W Russell; J Mestecky
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

5.  Coproantibodies in hepatitis A: detection by enzyme-linked immunosorbent assay and immune electron microscopy.

Authors:  S A Locarnini; A G Coulepis; J Kaldor; I D Gust
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

6.  Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates.

Authors:  J Sancho; E González; F Rivera; J F Escanero; J Egido
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

7.  Interactions of galactosyltransferase with serum and secretory immunoglobulins and their component chains.

Authors:  M Tomana; J Zikan; R Kulhavy; J C Bennett; J Mestecky
Journal:  Mol Immunol       Date:  1993-02       Impact factor: 4.407

8.  Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor.

Authors:  P W Mason; B Baxt; F Brown; J Harber; A Murdin; E Wimmer
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

9.  Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.

Authors:  L H Ping; S M Lemon
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 10.  Relapsing hepatitis A. Review of 14 cases and literature survey.

Authors:  M Glikson; E Galun; R Oren; R Tur-Kaspa; D Shouval
Journal:  Medicine (Baltimore)       Date:  1992-01       Impact factor: 1.889

View more
  28 in total

1.  A single mutation in the glycophorin A binding site of hepatitis A virus enhances virus clearance from the blood and results in a lower fitness variant.

Authors:  M Isabel Costafreda; Enric Ribes; Angels Franch; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions.

Authors:  Cecilia Tami; Erica Silberstein; Mohanraj Manangeeswaran; Gordon J Freeman; Sarah E Umetsu; Rosemarie H DeKruyff; Dale T Umetsu; Gerardo G Kaplan
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Vectorial entry and release of hepatitis A virus in polarized human hepatocytes.

Authors:  Michelle J Snooks; Purnima Bhat; Jason Mackenzie; Natalie A Counihan; Nicola Vaughan; David A Anderson
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 4.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 5.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

6.  Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA.

Authors:  Kerstin Brack; Iris Berk; Thomas Magulski; Jörg Lederer; Andreas Dotzauer; Angelika Vallbracht
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes.

Authors:  Bertrand Saunier; Miriam Triyatni; Luca Ulianich; Padma Maruvada; Paul Yen; Leonard D Kohn
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.

Authors:  Volker Fensterl; Dajana Grotheer; Iris Berk; Stefanie Schlemminger; Angelika Vallbracht; Andreas Dotzauer
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Evolutionary origins of hepatitis A virus in small mammals.

Authors:  Jan Felix Drexler; Victor M Corman; Alexander N Lukashev; Judith M A van den Brand; Anatoly P Gmyl; Sebastian Brünink; Andrea Rasche; Nicole Seggewiβ; Hui Feng; Lonneke M Leijten; Peter Vallo; Thijs Kuiken; Andreas Dotzauer; Rainer G Ulrich; Stanley M Lemon; Christian Drosten
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

10.  A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes.

Authors:  Jia Liu; Bin Hu; Yan Yang; Zhiyong Ma; Yuan Yu; Shenpei Liu; Baoju Wang; Xiping Zhao; Mengji Lu; Dongliang Yang
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.